ZA201105917B - Prodrug forms of kinase inhibitors and their use in therapy - Google Patents

Prodrug forms of kinase inhibitors and their use in therapy

Info

Publication number
ZA201105917B
ZA201105917B ZA2011/05917A ZA201105917A ZA201105917B ZA 201105917 B ZA201105917 B ZA 201105917B ZA 2011/05917 A ZA2011/05917 A ZA 2011/05917A ZA 201105917 A ZA201105917 A ZA 201105917A ZA 201105917 B ZA201105917 B ZA 201105917B
Authority
ZA
South Africa
Prior art keywords
therapy
kinase inhibitors
prodrug forms
prodrug
forms
Prior art date
Application number
ZA2011/05917A
Inventor
Jeffrey Bruce Smaill
Adam Vorn Patterson
Michael Patrick Hay
William Alexander Denny
William Robert Wilson
Guo-Liang Lu
Robert Forbes Anderson
Ho Huat Lee
Amir Ashoorzadeh
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/NZ2010/000040 external-priority patent/WO2010104406A1/en
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Publication of ZA201105917B publication Critical patent/ZA201105917B/en

Links

ZA2011/05917A 2009-03-11 2011-08-12 Prodrug forms of kinase inhibitors and their use in therapy ZA201105917B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NZ57549009 2009-03-11
NZ57945809 2009-09-02
NZ58117000 2009-11-12
PCT/NZ2010/000040 WO2010104406A1 (en) 2009-03-11 2010-03-11 Prodrug forms of kinase inhibitors and their use in therapy

Publications (1)

Publication Number Publication Date
ZA201105917B true ZA201105917B (en) 2012-06-27

Family

ID=56363296

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/05917A ZA201105917B (en) 2009-03-11 2011-08-12 Prodrug forms of kinase inhibitors and their use in therapy

Country Status (1)

Country Link
ZA (1) ZA201105917B (en)

Similar Documents

Publication Publication Date Title
IL214626A0 (en) Prodrug forms of kinase inhibitors and their use in therapy
HK1160119A1 (en) Kinase inhibitors and methods of use
EP2252293A4 (en) Kinase inhibitors and methods of use
IL207865A0 (en) Pim kinase inhibitors and methods of their use
EP2429566A4 (en) Cyclin dependent kinase inhibitors and methods of use
IL240771A0 (en) Benzoxazole kinase inhibitors and methods of use
SI2556071T1 (en) Kinase inhibitors and their use in treating cancer
IL211549A0 (en) Aminotriazolopyridines and their use as kinase inhibitors
IL218555A0 (en) Pi3 kinase inhibitors and uses thereof
EP2521549A4 (en) Therapeutic compounds and related methods of use
EP2696683A4 (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors
ZA201108622B (en) Pyrazolopyrimidines and related heterocycles as kinase inhibitors
EP2534145A4 (en) Therapeutic methods and compositions involving allosteric kinase inhibition
IL218182A0 (en) Kinase inhibitors, prodrug forms thereof and their use in therapy
EP2384118A4 (en) Sphingo-guanidines and their use as inhibitors of sphingosine kinase
IL206891A0 (en) Therapeutic inhibitors of pai-1 function and methods of their use
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
HK1166781A1 (en) Acrylamide derivative and use thereof in manufacture of medicament
ZA201300012B (en) Synthesis and use of kinase inhibitors
ZA201105917B (en) Prodrug forms of kinase inhibitors and their use in therapy
RS55471B1 (en) Kinase inhibitors and their use in treating cancer